(Q43289269)

18 November 2017

title

Response to medical treatment in patients with Crohn's disease: the role of NOD2/CRAD15, disease phenotype, and age of diagnosis (English)

1 reference

18 November 2017

1 reference

6

1 reference

18 November 2017

B Weiss

1

1 reference

18 November 2017

O Lebowitz

2

1 reference

18 November 2017

H H Fidder

3

1 reference

18 November 2017

I Maza

4

1 reference

18 November 2017

A Levine

5

1 reference

18 November 2017

S Reif

7

1 reference

18 November 2017

Y Bujanover

8

1 reference

18 November 2017

A Karban

9

1 reference

18 November 2017

publication date

20 August 2009

1 reference

Digestive Diseases and Sciences

18 November 2017

published in

1 reference

18 November 2017

volume

55

1 reference

18 November 2017

issue

6

1 reference

18 November 2017

page(s)

1674-1680

1 reference

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-0936-8

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-0936-8

IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-0936-8

Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-0936-8

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

12 December 2020

Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease

1 reference

12 December 2020

High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance.

1 reference

12 December 2020

Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients

1 reference

12 December 2020

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

1 reference

12 December 2020

Crohn's disease: influence of age at diagnosis on site and clinical type of disease

1 reference

12 December 2020

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

1 reference

12 December 2020

Frequency of glucocorticoid resistance and dependency in Crohn's disease

1 reference

12 December 2020

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease

1 reference

12 December 2020

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

1 reference

12 December 2020

Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn's disease

1 reference

12 December 2020

Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease

1 reference

12 December 2020

Clinical pattern of corticosteroid dependent Crohn's disease.

1 reference

12 December 2020

Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach--EPACT.

1 reference

12 December 2020

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

1 reference

12 December 2020

Treatment of inflammatory bowel disease in childhood: best available evidence

1 reference

12 December 2020

Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing

1 reference

12 December 2020

NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease

1 reference

12 December 2020

A simple index of Crohn's-disease activity

1 reference

12 December 2020

The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study

1 reference

12 December 2020

Polymorphisms of Tumor Necrosis Factor-α but Not MDR1 Influence Response to Medical Therapy in Pediatric-Onset Inflammatory Bowel Disease

1 reference

12 December 2020

NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease

1 reference

12 December 2020

Intercenter variation in initial management of children with Crohn's disease

1 reference

12 December 2020

Guidelines for the management of growth failure in childhood inflammatory bowel disease

1 reference

12 December 2020

10.1007/S10620-009-0936-8

Identifiers

DOI

1 reference

18 November 2017

1 reference